Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Diana Anderson

Diana Anderson

University of Bradford UK

Michael Retsky

Michael Retsky

Harvard TH Chan School of Public Health USA

Mohamed El-Far

Mohamed El-Far

Mansoura University Egypt

Vanessa Bellat

Vanessa Bellat

Weill Cornell Medicine USA

Melvin L DePamphilis

Melvin L DePamphilis

National Institute for Child Health & Human Development USA

Leroy J. Lowe

Leroy J. Lowe

Leroy J. Lowe UK

Janio Szklaruk

Janio Szklaruk

UT MD Anderson Cancer Center USA

Marja T Nevalainen

Marja T Nevalainen

Medical College of Wisconsin Cancer Center, USA

cancer-research-2019

About Conference


Conferenceseries LLC.Ltd  is glad to invite all the participants across the globe to attend European meet on Cancer research and Therapy scheduled during October 21-22, 2019  in Lisbon, Portugal which will mark the gathering of many renowned Oncologists, Pharmacologists, Healthcare Professionals, Researchers, Academicians, Students and Business Delegates.

Cancer Research 2019 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading universities, clinical research institutions, and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Sessions

Track01: Cancer: Mode of existence

Cancers may be benign or malignant. Benign cancers fail to spread to other tissues and is non-life threatening. Malignant Tumors are invasive and spread to different tissues within the area. Diverse kinds of tumors are present till date and many are beneath research investigation. Most cancers are a disease involving abnormal cell growth spread to different parts of the body. There are over distinct varieties of cancer, they may be divided into groups, each is assessed with the aid of the type of cell this is first affected. Cancer harms the body while cells divide uncontrollably to form masses or lumps of tissue this will cause an increase known as a tumour. The important lifestyle factors include alcohol, tobacco, diet, obesity; infectious agents, environmental pollutants, and radiation increase the mortality of cancer. Tobacco use increases the threat of developing at least 14 types of cancer. The chronic alcohol consumption is a risk factor for cancers of the upper aero digestive tract, including cancers of the oral cavity, pharynx, hypopharynx, larynx, and esophagus. Numerous air pollutants such as PAHs (polycyclic aromatic hydrocarbons) increase the risk of lung cancer. Carcinomas are cancers of epithelial cells. The lesser hereditary impact of cancer and the modifiable nature of the environmental factors direct to the preventability of cancer

  • Alcohol and Tobacco
  • Diet and Obesity
  • Environmental pollutants
  • Radiation
  • Magnetic Resonance Imaging
  • Endoscopic Ultrasound
  • Tumor Molecular Profiling
  • X-Ray
  • Nuclear Medicine Imaging

Track02: Cancer Genetics and Epigenetics

Cancer is a genetic disease caused by changes in certain genes that control the way of our cells function particularly how they develop and divide. Genes carry the guiding principle to make proteins, which do much of the work in our cells. Others result in the production of a misshapen, and therefore non-functional, form of a protein that normally repairs cellular damage.

  • Oncogenes
  • Proto-Oncogenes
  • Tumour Suppressor genes
  • DNA Repair Genes
  • DNA Repair Genes
  • Cancer Genomics
  • Cancer Genome Sequencing

Cancer is basically a disease of tissue growth regulation. In order for a normal cell to transform into a Cancer cell, the genes that control cell growth and variation must be altered. The affected genes are divided into two broad categories: Oncogenes and Tumor Suppressor Genes. Oncogenes are genes that stimulate cell growth and reproduction. Tumor Suppressor Genes are genes that prevent cell division and survival. Malignant alteration can arise through the development of novel Oncogenes, the unfortunate over-expression of typical Oncogenes, or by the under-expression or inactivating of Tumor Suppressor Genes. Usually, alterations in Multiple Genes are essential to transform a normal cell into a Cancer cell.

Cancer Epigenetics deals with the Epigenetic Alterations to the genome of Cancer cells that do not comprise any change in the nucleotide sequence. Epigenetic Alterations are as vital as Genetic Mutations in a normal cell conversion to Cancer cells, and their manipulation holds great promise for Cancer prevention, detection, and therapy.

Track03: Cancer Biomarkers

A cancer biomarker refers to an element or procedure that is indicative of the presence of cancer in the body. A biomarker may be a molecule released by a presence of tumour or a specific response of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology. The most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to. So many pharmaceutical companies were producing different sort of biomarkers. So, it plays a vital role in the treatment in cancer.

  • Types of Cancer Biomarkers
  • Biomarkers in Drug Discovery
  • Biomarkers in Cancer Screening
  • Biomarkers in Pharmacokinetics
  • Biomarkers in Pharmacodynamics

Track04: Cancer Science

Cancer Science is a medical field that covers every branch of cancer research and therapy. Cancer was considered as deadly disease few years ago, but now the development has changed thanks to advances made in the cancer field. There are diverse therapies available now to treat and diagnose cancer. The Targeted Cancer Therapy is one of the best therapies available, in which the cancer cells are treated by targeting and inhibiting specific molecules that are responsible for tumor progression. This blocking can be done by medicine. The Cancer Case Reports shows that Stem Cell Therapy is also an effective treatment for cancer. Cancer biomarkers assist in finding tumor cells and treating them. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics.

  • Clinical Research
  • Drug Discovery and Delivery
  • Genetics, Genomics and Proteomics
  • Cell, Molecular and Stem Cell Biology
  • Bone Marrow Transplantation
  • Hormone Replacement Therapy
  • Surgery and Laparoscopy
  • Molecular Targeted Therapies
  • Natural Therapy and Acupuncture

Track05: Organ Specific Cancers

Cancer can occur anywhere in the body. The most common sites of cancer among men include lung, prostate, colon, rectum, stomach and liver. And those for among women are breast, colon, rectum, lung, cervix and stomach. Cancers are often described by the body part that they originated in. However, some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as different types of cancer can behave very differently and respond to different treatments. Cancer is one of the leading causes of death all over the world. Organ Specific Cancers are cancers named based on the location of cancer in the body organ. Its incidence is showing an increasing trend in various parts of the earth and has been a significant public health problem despite advances in the understanding of the molecular and cellular events that underlie.

  • Breast Cancer
  • Gynaecologic Cancers
  • Brain Cancer
  • Bone Cancer
  • Prostate Cancer
  • Lung Cancer
  • Leukaemia
  • Skin Cancer

Track06: Surgical Oncology

Surgical oncology is the branch of surgery applied to oncology and it focuses on the surgical management of tumors, especially cancerous tumors. There are currently 19 surgical oncology fellowship training programs in the United States that have been approved by the Society of Surgical Oncology and this number is expect to grow. The collaboration with radiation and medical oncologists on the use of neoadjuvant chemotherapy or radiotherapy to enhance or permit surgery possible and on the indications for adjuvant therapy after surgery. The technical side of surgery has also been transformed in the past few decades with advance techniques

  • Transanal Endoscopic Microsurgery
  • Robotic surgery
  • Reconstructive surgery
  • Laparoscopic cancer surgery
  • Cytoreductive surgery with HIPEC
  • Sarcoma surgery

Track07: Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. Radiation oncology is a medical arena that involves the controlled use of radiation to treat cancer either for cure or to reduce pain and symptoms caused by cancer. Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiation therapy and/or radiotherapy are broadly segmented into Brachy-radiotherapy, Teleradiotherapy and Metabolic Radiotherapy. There are three unique Radiology specialist professions which are involved in practice of radiation oncology 1. Radiation Oncologists 2. Radiation Therapists 3. Radiation Oncology Medical Physicists. These highly trained medical specialists who use advanced technologies on Cancer patients to deliver safe and effective radiation therapy with few side effects as possible.

  • External Beam Radiation Therapy / Telotherapy
  • Internal Radiotherapy / Brachytherapy
  • Systemic Radioisotope Therapy
  • Intraoperative Radiotherapy
  • Radioisotope Therapy
  • DIBH Technique
  • Stereotactic Radiation and Radiosurgery
  • Postoperative Radiotherapy

Track08: Cancer Biopsy

A biopsy is a medical examination usually done by a surgeon, an interventional radiologist, or an interventional cardiologist concerning extraction of sample cells or tissues for scrutiny to determine the existence of a disease state. Mainly the biopsy is of two categories, the excisional biopsy in which the affected tissues or cells are removed entirely and the incisional biopsy in which some sample is extracted from the affected region for diagnosis. When cancer is suspected, the first attempt will be excisional biopsy if it doesn’t work they will go for incisional biopsy to determine whether the cancer is benign or malignant. Sometimes in biopsy if the area of suspicion is not found, X- rays or ultrasound can be used to trace the area it is known as ultra sound guided biopsy or stereotactic guided biopsy. The safest mode of diagnosis and a minor surgical procedure is called fine needle aspiration. A noninvasive method of diagnosing cancer is liquid biopsy. Cancer pathogenesis is considered as a most important procedure after biopsy. Oncology - Clinical Trials, in which the biopsy is considered as an important technique. Cancer Science and Therapy Conferences paves a way towards a break-through in cancer research field. 

  • Excisional biopsy
  • Incisional biopsy
  • Liquid biopsy
  • Stereotactic guided biopsy
  • Fine needle aspiration

Track09: Cancer Pharmacology

Pharmacology deals with action of drug in the body.  Drugs showed good results in animal model, when used in cancer patient of less tumor burden was not so effective. In such case the tumor burden can be reduced first by cancer surgery and it is followed by chemotherapy can be done, this is called as adjuvant therapy. In combination with chemotherapy, a heat therapy called hyperthermia therapy can be used to control various cancer types. The electric volts are passed on the tumor cells to stop there progression along with chemotherapy is known as electrochemotherapy. The use of chemotherapy alone for cancer treatments leads to many side effects like cardiotoxicity, nephrotoxicity, ototoxicity etc., Cancer genetics will be helpful for identifying the mode of treatment for Cancer. Cancer biomarkers effectively assist in finding tumor cells and treating them. Cancer Conferences gives a perception about the new strategies emerging in cancer therapy

  • Tumour Targeting Strategies
  • Hormonal & Biological Agents
  • Cancer Drug Targets
  • Clinical Trials
  • Anticancer Therapeutics
  • Preclinical Models for Drug Evaluation
  • Research and Analytical Methods

Track10: Cell and Gene Therapy for Cancer

Cell Therapy goes for focusing on different diseases at the cellular level, i.e. by re-establishing a definite cell populace or using cells as therapeutic cargo. Gene Therapy deals with biomedical investigation with the objective of impacting the course of different hereditary and procured diseases at the DNA/RNA level. For utmost diseases, cell and gene therapy are applied in combination. Moreover, these two fields have given ideas, reagents, and techniques that are lighting up the improved purposes of quality control, stem cell lineage, cell-cell interactions, input circles, enhancement circles, regenerative limit, and redesigning or remodeling.

  • Understanding of the genetic basis of cancer
  • Developed methods for isolating, expanding and engineering cancer-killing cells
  • Enhancing the immunogenicity of the tumor by introducing genes therapy

Track11: Cancer Therapy

Cancer can be treated by different methods. The treatment depends on the location, Stage and grade of the cancer. Bone Marrow transplantation is a therapy that takes place in case of leukemia lymphoma and myeloma. In Radiation therapy, the patient is treated with the ionization radiations which destroys the cancer cells. Chemotherapy, in which anti-cancer drugs are used to treat the cancer. Cancer Immunotherapy is a type of treatment in which the immune system is trigged to treat the cancer. Some cancers will be sensitive to hormones so by inhibiting or removing the specific hormones, the cancer growth can be controlled, it can be called as Hormone Therapy. The metastatic cancers can be best treated with Targeted therapy, in which the location of cancer can be targeted easily. Many novel Approaches to Cancer Therapeutics are being exposed in the cancer science and therapy field. Cancer Science and Therapy Conferences are an endeavor to procure mastery in cancer research field.

  • Gene Therapy
  • Immunotherapy
  • Biomarkers in cancer detection
  • Radiation Therapy
  • Chemotherapy
  • Bone Marrow Transplantation
  • Hormone Replacement Therapy
  • Molecular Targeted Therapies

Track12: Chemotherapy

Cancer chemotherapy involves the selection of drugs and dose levels, which will eradicate disseminated cancer cells, without causing severe host toxicity. Depending on the primary location and the extension of the disease, chemotherapy can be curative or palliative. In the majority of cases, Chemotherapy leads to the prolongation of survival, and in other cases it results in the eradication of the disease. Chemotherapy can be in most cases a major adjuvant to surgical therapy and/or radiotherapy. It is most successful against Leukemias. Mechanism-based approaches have also been explored for several decades. About 30 chemotherapeutic drugs are in regular use in the treatment of cancer till date. All Antitumor drugs may be placed into one of three classes based on the relationship of the effect to the mitotic cycle of the cell:

1. Cell cycle active, phase specific

2. Cell cycle active, phase non-specific

3. Non-cell cycle active.

  • Types of Chemotherapy
  • Combination Chemotherapy
  • Cancer Chemotherapy Side Effects
  • Cancer Chemotherapy Resistance

Track13: Cancer Therapeutics and Novel Approaches

In cancer treatment the already existing treatments are severely related to many side effects and are highly poisonous, which will reduce the quality of life. This incorporates the discovery of novel approaches in cancer treatment. The most important approach is the cancer immunotherapy, in which the activation of immune system happens for the treatment of cancer. Traditionally the Cytokine therapy is considered as a backbone of immunotherapy for cancer. The vaccines like peptide vaccines, tumor cell vaccines, immune cell vaccines, cancer vaccines are considered as a novelist finding in cancer field. In hematologic malignancy the adoptive cell therapy is deliberated as a new practice for cancer therapy. The molecular cancer therapy is reflected as a novel approach in cancer treatment. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics. Cancer Conferences expresses its effort to combat cancer.

  • Cancer Epigenetics
  • Molecular Profiling Techniques
  • New Biologics & Vaccines
  • Chemical Proteomics
  • Combination Strategies in Immuno-oncology
  • Novel Biomarker Discovery

Track14: Cancer Alternative Medicine

Cancer Alternative Medicine includes Complementary and Alternative Medicine, which are generally non-mainstream practices. Recently Cancer Alternative Medicine therapies are gaining importance in managing adverse symptoms of Cancer. If a non-mainstream treatment is used together with conventional medicine, it’s considered as “Complementary treatment.” If a non-mainstream treatment is used in place of conventional medicine, it’s considered as “Alternative treatment.” Cancer Alternative Medicine consists of treatments that are based on prescientific concepts of human pathology and physiology. Most people who use non-mainstream approaches use them along with conventional treatments. Cancer Alternative Medicine therapies include a varied variety of nutritional products, such as and botanicals dietary supplements, vitamins and herbal supplements

  • Acupuncture
  • Ayurveda
  • Homeopathy
  • Naturopathy
  • Chinese Medicine
  • Unani Medicine
  • Herbal medicine

Track15: Cancer Drugs

Cancer or its treatment can lower your resistance to infection and make you more likely to catch the other diseases. There are many different types of cancer drugs. Some drugs can treat cancer and the others help to relieve symptoms such as pain and sickness. The type of drugs you need to use for cure of your cancer depends on what type of cancer you have. Drug therapies work in diverse ways to destroy cancer cells and stop them from spreading or slow down their development. Anticancer drugs or anticancer agents are used in Cancer. Drugs may also be used to reduce or relieve side effects of cancer and its treatment.

  • Cancer Drug Discovery
  • Cancer Drug Delivery
  • Cancer Drug Resistance
  • Cancer Clinical trials
  • Types of Cancer Drugs

Track16: Cancer Vaccines

Cancer Vaccines typically either treats existing cancer or prevents development of a cancer. The drug is useful in treating the cancer. It’s been classified into many categories which incorporates natural product, alkylating agents, hormones, antimetabolites. Cancer treatment vaccines are created of cancer cells, elements of cells, or pure antigens. Typically a patient’s own immune cells are removed and exposed to those substances within the research laboratory to make the vaccines. Therapeutic vaccines represent a viable possibility for active therapy of cancers that aim to treat late stage of cancer by employing a patient's own system.

  • Tumour Immunology
  • Prophylactic Vaccines
  • HPV Vaccines
  • Oncoviruses

Track17: Cancer Immunology & Immunotherapy

Cancers immunology is a branch of immunology that describes about the research interactions among the immune system and cancer cells. Its field of study that goals to find out cancer immunotherapies to deal with and retard progression of the Disease. Cancer immunotherapy additionally called immuno-oncology is using the immune device to treat cancer. Immunology may be categorized as active, passive or hybrid (active and passive). The immune response, along with the recognition of most cancers-specific antigens, forms the basis of targeted therapy (along with vaccines and antibody procedures) and tumour marker-based diagnostic tests.

  • Cancer Immunology
  • Cellular Immunotherapy
  • Antibody Therapy
  • Cytokine Therapy
  • Cancer Targetted Therapies
  • Gene Induced Immunotherapy

Track18: Cancer case Report

The case reports are something which gives thorough details about the diagnosis, treatments and further follow ups, the demographic profiles of the patient. The literature review of other patients may also present in a report for the reference. In cancer metastasis the case plays an important role for treating the patient. On another hand, it also makes a good cancer therapy database which will be useful for education and research. The cancer pathogenesis and its effects can also be depicted in a case report. The case report is considered as an anecdotal evidence, something which is considered very personal. Statistical sampling of the cancer patients may also present in a case report for reference. It is considered as a patient history, which will be more helpful in case of cancer. Cancer Therapy Conferences is a platform to innovate novel therapy for cancer.

  • Unexpected/Unusual Conditions
  • Rare Surgical Condition of a cancer case
  • Novel Surgical Procedure
  • Adverse Effects
  • Adverse Effects

Track19: Cancer Prevention and Management

The cancer prevention is mainly to reduce the risk of acquiring cancer. There are many factors that we have to consider to prevent cancer, they are leading a healthy life style, avoiding the carcinogens and related substances, consuming cancer vaccines that prevent cancer. The cancer management can be done by many ways depending upon the stage of the cancer. The cancer surgery is the best option in the early stage. Apart from surgery there are many therapies to manage the cancer. The immunotherapy that helps in stimulating the immune system to treat cancer. Some people will also go for alternative medicine. The precision therapies or the precision medicines can also be used to treat cancer.Inspite of all treatment and management, in latter stages of cancer only the palliative care can be given to the patients to comfort them. Cancer Science and Therapy Conferences discloses the contemporary changes in cancer field.

  • Lifestyle changes
  • Diet & Cancer
  • Vaccinations
  • Natural Therapy
  • Psychological & Social Aspects

Why to attend

  • Present your research, share your expertise, hear case studies and gain practical information to ensure success in cancer management and research in the world;
  • Participate in workshops led by an expert speaking faculty;
  • Broaden your network for clinical support, collaboration and education;
  • Keep up to date and make empowered and educated decisions on what is happening in the field of cancer in the world;
  • Access more than twenty hours of networking with cancer professionals from +150 different countries across all fields.

Market Analysis

Market Analysis Report:

Cancer is a disease characterized by the abandoned growth and spread of abnormal cells. If the growth of abnormal cells is not controlled, it can result in death. In Worldwide, one in seven deaths is due to cancer.  cancer causes more deaths than AIDS, tuberculosis, and malaria. According to income when countries are grouped, cancer is the second leading cause of death in high-income countries (following cardiovascular diseases) and the third leading cause of death in low- and middle-income countries (following cardiovascular diseases and infectious and parasitic diseases).

Cancer Diagnostics Market:

The global market size of cancer diagnostics is expected to reach $22.7 billion from $7.1 billion in 2015. Growing prevalence of oncologic cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world.

 

Rising awareness and supportive government enterprises are some other factors that are anticipated to increase the growth of the sector during the forecast period. The global cancer diagnostics market is fragmented based on technology, application, and region.  Increase in aging population and cancer cases are likely to create huge opportunity for cancer diagnostics.

Cancer Diagnostic Market, By Technology

 On the basis of technology, the cancer diagnostics market is divided into instrument-based and platform-based. In 2015, the instrument-based segment is predicted to account for a major share of the cancer diagnostics market, by product.

1) Platform Based:

  • In situ Hybridization
  • Flow Cytometry
  • Next-generation Sequencing
  • Microarrays
  • Others

2) Instrument Based:

  • Biopsy
  • Mammography
  • PET
  • Ultrasound
  • MRI
  • CT

Cancer Diagnostic Market, By Application

Based on the application, the diagnostics market is fragmented into breast cancer, lung cancer, colorectal cancer, melanoma, Leukemia and others. Breast cancer application is expected to account for a major portion of the cancer diagnostics market.

 

 

Cancer Diagnostic Market, By Region

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

 

Past Conference Report

Euro Cancer 2018

Thanks to all our Speakers and conference attendees of Euro Cancer 2018 Conference

29th Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 23-25, 2018 at Rome, Italy. The conference organized with a focus on Scrutinizing Progressive Cancer Research in Diagnosis, Treatment and Prevention” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promote the theme with their elegant talk were:

  • Jaime Tisnado                          

Virginia Commonwealth University, USA

  • Christopher S Lange

Downstate Medical Center, Brooklyn, NY, USA

  • Carina Mari Aparici

University of California, USA

  • Antonio Gómez-Muñoz

University of the Basque Country, Spain

  • Shinji Osada

Gifu Municipal Hospital, Japan

  • Kang-Yell Choi

Yonsei University, South Korea

  • Rufadie Maxhuni

Clinical University Center of Kosovo, Pristina


Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Cancer 2018, we would like to announce the commencement of the “ European meet on Cancer Research & Therapy" held during October 21-22, 2019 at Lisbon, portugal.We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology Research.

 

More Info

Cancer Institutions

European Cancer Institutions

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam ; Leiden University;  RWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

USA Cancer Institutions

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Asian Cancer Institutions

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

African Cancer Institutions

Makerere University; University of Ghana At Legon; University of Nairobi ; University of Ibadan; University of Botswana; University of Lagos; Cheikh Anta Diop University ; University of Dar Es Salaam; University of Cape Town; Stellenbosch University; University of Pretoria; Cairo University; University of Witwatersand; University of Kwazulu-Natal; University of Western Cape; Mansoura University; University of Johanessburg; Orotta School of Medicine; Addis Ababa University; Aga Khan University Medical School; Egerton University Medical School; University of Malawi College of Medicine; Ambrose Alli University; Walter Sisulu University; Busitema University School of Medicine

To Collaborate Scientific Professionals around the World

Conference Date

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Cancer Science & Therapy Journal of Integrative Oncology Journal of Carcinogenesis & Mutagenesis Advances in Cancer Prevention

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by